The Influence of Fortified Pomegranate Juice (Punica Granatum) on Seasonal Influenza and Swine Flu Patients
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2009 by Hillel Yaffe Medical Center.
Recruitment status was Not yet recruiting
Recruitment status was Not yet recruiting
Sponsor:
Hillel Yaffe Medical Center
Collaborator:
Gan-Shmuel Foods, Ltd.
Information provided by:
Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier:
NCT00987012
First received: September 29, 2009
Last updated: NA
Last verified: September 2009
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
It has been shown in laboratory studies that pomegranate juice contains anti-viral action against influenza. The researchers wish to investigate the effect of pomegranate juice on patients suffering from influenza A (seasonal or swine flu).
| Condition | Intervention |
|---|---|
|
Influenza A Swine Flu |
Dietary Supplement: Pomegranate juice Dietary Supplement: Placebo drink |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Treatment |
| Official Title: | The Influence of Fortified Pomegranate Juice (Punica Granatum) on Seasonal Influenza and Swine Flu Patients - A Prospective Randomized Trial |
Resource links provided by NLM:
Further study details as provided by Hillel Yaffe Medical Center:
Primary Outcome Measures:
- Early relief of influenza symptoms [ Time Frame: Within one week ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 200 |
| Study Start Date: | October 2009 |
| Estimated Primary Completion Date: | April 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Pomegranate juice |
Dietary Supplement: Pomegranate juice
Twice daily ingestion of pomegranate juice over 4-5 days
|
| Placebo Comparator: Placebo drink |
Dietary Supplement: Placebo drink
Twice daily ingestion of placebo drink over 4-5 days
|
Eligibility| Ages Eligible for Study: | 12 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Individuals confirmed and suffering from Influenza A
Exclusion Criteria:
- Individuals suffering from influenza included in the high risk group
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00987012
Locations
| Israel | |
| Hillel Yaffe Medical Center | Not yet recruiting |
| Hadera, Israel, 38100 | |
| Contact: Gershon Keren, MD 972-4-6304218 gershonk@hy.health.gov.il | |
| Contact: Izhak Braverman, MD | |
Sponsors and Collaborators
Hillel Yaffe Medical Center
Gan-Shmuel Foods, Ltd.
More Information
No publications provided
| Responsible Party: | Dr. Gershon Keren, Hillel Yaffe Medical Center |
| ClinicalTrials.gov Identifier: | NCT00987012 History of Changes |
| Other Study ID Numbers: | 0044-09-HYMC |
| Study First Received: | September 29, 2009 |
| Last Updated: | September 29, 2009 |
| Health Authority: | Israel: Ministry of Health |
Additional relevant MeSH terms:
|
Influenza, Human Orthomyxoviridae Infections RNA Virus Infections |
Virus Diseases Respiratory Tract Infections Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on May 16, 2013